Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.55 |
| ▸ | CA2 | P00918 | 8/20 | 0.55 |
| ▸ | CA4 | P22748 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | ATR | Q13535 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 6/20 | 0.38 |
| ▸ | CA9 | Q16790 | 6/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.30 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL673134 | 0.95 | — | — | |
| SCHEMBL27931913 | 0.90 | CA1 (0.55) | CA1CA2CA4TSHRATM | |
| Zinc Ion SCHEMBL1765831 | 0.90 | CA1 (0.55) | CA1CA2CA4TSHRATM | |
| SCHEMBL36485 | 0.89 | CA1 (0.67) | CA1CA2CA4TSHRATM | |
| SCHEMBL451236 | 0.89 | — | — | |
| SCHEMBL29742330 | 0.89 | CA1 (0.67) | CA1CA2CA4TSHRATM | |
| SCHEMBL23573895 | 0.84 | — | — | |
| SCHEMBL20919779 | 0.84 | CA1 (0.60) | CA1CA2CA4TSHRATM | |
| Water SCHEMBL21082889 | 0.84 | — | — | |
| SCHEMBL20508254 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012104204-A1 | IRON-CARBOHYDRATE COMPLEX COMPOUNDS FOR THE INTRAVENOUS THERAPY OF MALARIA | VIFOR (INTERNATIONAL) AG (CH) | 2012-08-09 | — | — | WO | disclosed |
| US-20030203887-A1 | Methods for in vivo reduction of free radical levels and compostions useful therefor | MCW RESEARCH FOUNDATION, INC., | 2003-10-30 | — | — | US | disclosed |
| US-20030203887-A1 | Methods for in vivo reduction of free radical levels and compostions useful therefor | MCW RESEARCH FOUNDATION, INC., | 2003-10-30 | — | — | US | disclosed |
| US-20030040511-A1 | Methods for in vivo reduction of free radical levels and compositions useful therefor | MCW RESEARCH FOUNDATION, INC. | 2003-02-27 | — | — | US | disclosed |
| US-20030040511-A1 | Methods for in vivo reduction of free radical levels and compositions useful therefor | MCW RESEARCH FOUNDATION, INC. | 2003-02-27 | — | — | US | disclosed |
| US-6469057-B1 | TREATMENTS FOR EXCESS FREE RADICAL PRODUCTION BY USE OF DITHIOCARBAMATES AS SCAVENGERS; COMPLEXES FORMED ARE EXCRETED INTO URINE | MCW RESEARCH FOUNDATION, INC. | 2002-10-22 | — | — | US | disclosed |
| US-6469057-B1 | TREATMENTS FOR EXCESS FREE RADICAL PRODUCTION BY USE OF DITHIOCARBAMATES AS SCAVENGERS; COMPLEXES FORMED ARE EXCRETED INTO URINE | MCW RESEARCH FOUNDATION, INC. | 2002-10-22 | — | — | US | disclosed |
| WO-2002026225-A1 | METHODS FOR IN VIVO REDUCTION OF FREE RADICAL LEVELS AND COMPOSITIONS USEFUL THEREFOR | MCW RESEARCH FOUNDATION, INC. (US) | 2002-04-04 | — | — | WO | disclosed |
| WO-2002026225-A1 | METHODS FOR IN VIVO REDUCTION OF FREE RADICAL LEVELS AND COMPOSITIONS USEFUL THEREFOR | MCW RESEARCH FOUNDATION, INC. (US) | 2002-04-04 | — | — | WO | disclosed |
| CN-1075816-C | Methods for in vivo reduction of nitric oxide levels and compositions useful therefor | MCW RES FOUND INC (US) | 2001-12-05 | — | — | CN | disclosed |
| EP-0866695-A1 | COMBINATIONAL THERAPEUTIC METHODS EMPLOYING NITRIC OXIDE SCAVENGERS | Medinox, Inc. (US) | 1998-09-30 | — | — | EP | disclosed |
| EP-0850240-A1 | METHODS FOR IN VIVO REDUCTION OF NITRIC OXIDE LEVELS AND COMPOSITIONS USEFUL THEREFOR | MCW Research Foundation, Inc. (US) | 1998-07-01 | — | — | EP | disclosed |
| US-5756540-A | ADMINISTERING A DITHIOCARBAMATE-CONTAINING SCAVENGER | MCW RESEARCH FOUNDATION, INC. (US) | 1998-05-26 | — | — | US | disclosed |
| US-5756540-A | ADMINISTERING A DITHIOCARBAMATE-CONTAINING SCAVENGER | MCW RESEARCH FOUNDATION, INC. (US) | 1998-05-26 | — | — | US | disclosed |
| US-5747532-A | Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor | MEDINOX, INC. (US) | 1998-05-05 | — | — | US | disclosed |
| US-5741815-A | TREATING INFLAMMATORY AND INFECTIOUS DISEASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 1998-04-21 | — | — | US | disclosed |
| US-5741815-A | TREATING INFLAMMATORY AND INFECTIOUS DISEASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 1998-04-21 | — | — | US | disclosed |
| WO-1997032585-A1 | COMBINATIONAL THERAPEUTIC METHODS EMPLOYING NITRIC OXIDE SCAVENGERS AND COMPOSITIONS USEFUL THEREFOR | MEDINOX, INC. (US) | 1997-09-12 | — | — | WO | disclosed |
| WO-1997018805-A1 | COMBINATIONAL THERAPEUTIC METHODS EMPLOYING NITRIC OXIDE SCAVENGERS | MEDINOX, INC. (US) | 1997-05-29 | — | — | WO | disclosed |
| WO-1996038457-A1 | METHODS FOR IN VIVO REDUCTION OF NITRIC OXIDE LEVELS AND COMPOSITIONS USEFUL THEREFOR | MCW RESEARCH FOUNDATION, INC. (US) | 1996-12-05 | — | — | WO | disclosed |